PIR and cancer: As our understanding of biological pathways regulated by HSF1 in supporting cancers deepens, such as the role of the PIKK family, CDK9, and Pirin in the inhibition of the HSF1 stress pathway, identification of new chemotypes as potential candidate for cancer therapy will be easier.